Related Experiment Video

Updated: Jul 9, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling

Jaroslaw Jozwiak, Mustafa Sahin, Sergiusz Jozwiak

    International Journal of Cardiology
    |November 27, 2007
    PubMed

    Insights

    Tuberous sclerosis (TS) is a neurological disorder. Cardiac rhabdomyomas in TS patients show hyperactivity in mTOR and Erk pathways, suggesting Erk potentiation drives tumor growth.

    Area of Science:

    • Cardiovascular Medicine
    • Neurology
    • Oncology

    Background:

    • Tuberous sclerosis (TS) is a genetic disorder causing tumors in multiple organs.
    • Cardiac rhabdomyomas are common early signs of TS, but their molecular basis is poorly understood due to infrequent surgical removal.

    Observation:

    • A patient with TS underwent surgical excision of a cardiac rhabdomyoma due to hemodynamic compromise.
    • The excised tumor retained heterozygosity for the affected TSC2 gene.

    Findings:

    • Analysis revealed hyperactivity in the mTOR and Erk signaling pathways within the rhabdomyoma.
    • While Akt was not upregulated, mTOR and Erk, along with their substrates, were hyperactive, with modest MEK activation.

    Implications:

    • This study suggests Erk pathway potentiation may be a key mechanism driving cardiac rhabdomyoma growth in tuberous sclerosis.
    • Understanding these molecular pathways could lead to targeted therapies for TS-associated tumors.

    More Related Videos

    Spatial and Temporal Analysis of Active ERK in the C. elegans Germline08:40

    Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

    Published on: November 29, 2016

    Related Concept Videos

    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    PI3K/mTOR/AKT Signaling Pathway01:22

    PI3K/mTOR/AKT Signaling Pathway

    The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
    Enzyme-linked Receptors01:00

    Enzyme-linked Receptors

    Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
    Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
    Receptor Tyrosine Kinases01:26

    Receptor Tyrosine Kinases

    Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
    Microtubules in Signaling01:22

    Microtubules in Signaling

    The primary cilium, made up of microtubules, acts as antennae on the cell surfaces for relaying external stimuli into the cells. These fine hair-like structures are present, generally one per cell. These are non-motile cilia in a 9+0 microtubules arrangement, where the central pair of microtubules are absent. The primary cilia arise from the basal body embedded in the cell membrane. Intraflagellar transport (IFT) carries requisite proteins from the cytoplasm to the cilium because the primary...
    The Ras Gene02:38

    The Ras Gene

    The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
    Ras is a superfamily...